Pricing Log in Create free account

Aclaris Therapeutics, Inc. (ACRS) vs Faeth Therapeutics, Inc. (FTH)

Aclaris Therapeutics, Inc. and Faeth Therapeutics, Inc. are both Biotechnology companies. Aclaris Therapeutics, Inc. and Faeth Therapeutics, Inc. are of similar size ($532.3M and $513.7M). Faeth Therapeutics, Inc. has the higher net margin (0.00% vs −921.5%) and the higher return on invested capital (0.00% vs −163.4%). Across the 13 metrics below, Faeth Therapeutics, Inc. leads on 7 and Aclaris Therapeutics, Inc. on 6.

Valuation

Metric ACRS FTH Biotechnology median
P/E n/m n/m 8.50
P/S 56.96 n/m 9.71
P/B 3.76 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.32 0.64
EV/Sales 47.13 n/m 9.21
Earnings yield (17.68%) (753.86%) (33.15%)
Free cash flow yield (13.28%) (31.94%) (25.50%)

Profitability

Metric ACRS FTH Biotechnology median
Gross margin 12.90% 0.00% 65.16%
Operating margin (1,050.16%) 0.00% 0.00%
Net margin (921.50%) 0.00% 0.00%
Free cash flow margin (756.50%) 0.00% 0.00%
Return on equity (59.10%) (195.26%) (56.36%)
Return on assets (41.07%) (176.88%) (48.04%)
Return on invested capital (163.35%) 0.00% 0.00%

Growth

Metric ACRS FTH Biotechnology median
Revenue growth (TTM) (51.04%) — 6.02%
EPS growth (last fiscal year) 69.01% 30.33% 30.26%
Revenue growth, 5-year CAGR 3.84% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRS FTH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.46 19.69 4.72
Net debt to EBITDA 1.20 0.96 0.96

Dividend

Metric ACRS FTH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACRS FTH Biotechnology median
Market cap 513.72m 532.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack